Grob, J. (., Amonkar, M. (. M., Martin-Algarra, S. (., Demidov, L. (. V., Goodman, V. (., Grotzinger, K. (., . . . Hauschild, A. (. (2014). Patient perception of the benefit of a BRAF inhibitor in metastatic melanoma: Quality-of-life analyses of the BREAK-3 study comparing dabrafenib with dacarbazine.
Citación estilo ChicagoGrob, J.J. (Jean-Jacques)|||/items/81200b16-b21e-4433-b311-c1d8512d8a03, et al. Patient Perception of the Benefit of a BRAF Inhibitor in Metastatic Melanoma: Quality-of-life Analyses of the BREAK-3 Study Comparing Dabrafenib With Dacarbazine. 2014.
Cita MLAGrob, J.J. (Jean-Jacques)|||/items/81200b16-b21e-4433-b311-c1d8512d8a03, et al. Patient Perception of the Benefit of a BRAF Inhibitor in Metastatic Melanoma: Quality-of-life Analyses of the BREAK-3 Study Comparing Dabrafenib With Dacarbazine. 2014.